de Rooij DJ - Search Results

1

Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies.

van den Hoogen FH, Spronk PE, Boerbooms AM, Bootsma H, de Rooij DJ, Kallenberg CG, van de Putte LB. van den Hoogen FH, et al. Among authors: de rooij dj. Br J Rheumatol. 1994 Dec;33(12):1117-20. doi: 10.1093/rheumatology/33.12.1117. Br J Rheumatol. 1994. PMID: 8000737

2

Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome.

Hoet RM, Koornneef I, de Rooij DJ, van de Putte LB, van Venrooij WJ. Hoet RM, et al. Among authors: de rooij dj. Arthritis Rheum. 1992 Oct;35(10):1202-10. doi: 10.1002/art.1780351013. Arthritis Rheum. 1992. PMID: 1384511

3

Marker antibodies in scleroderma and polymyositis: clinical associations.

de Rooij DJ, Van de Putte LB, Habets WJ, Van Venrooij WJ. de Rooij DJ, et al. Clin Rheumatol. 1989 Jun;8(2):231-7. doi: 10.1007/BF02030079. Clin Rheumatol. 1989. PMID: 2547546

4

Juvenile-onset mixed connective tissue disease: clinical, serological and follow-up data.

de Rooij DJ, Fiselier T, van de Putte LB, van Venrooij WJ. de Rooij DJ, et al. Scand J Rheumatol. 1989;18(3):157-60. doi: 10.3109/03009748909095413. Scand J Rheumatol. 1989. PMID: 2772563 No abstract available.

5

The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases.

de Rooij DJ, van de Putte LB, Habets WJ, Verbeek AL, van Venrooij WJ. de Rooij DJ, et al. Scand J Rheumatol. 1988;17(5):353-64. doi: 10.3109/03009748809105271. Scand J Rheumatol. 1988. PMID: 3062767

6

Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.

Haagsma CJ, van Riel PL, de Rooij DJ, Vree TB, Russel FJ, van't Hof MA, van de Putte LB. Haagsma CJ, et al. Among authors: de rooij dj. Br J Rheumatol. 1994 Nov;33(11):1049-55. doi: 10.1093/rheumatology/33.11.1049. Br J Rheumatol. 1994. PMID: 7981992 Clinical Trial.

7

Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease.

Hof D, Cheung K, de Rooij DJ, van den Hoogen FH, Pruijn GJ, van Venrooij WJ, Raats JM. Hof D, et al. Among authors: de rooij dj. Arthritis Res Ther. 2005;7(2):R302-9. doi: 10.1186/ar1490. Epub 2005 Jan 11. Arthritis Res Ther. 2005. PMID: 15743477 Free PMC article.

8

Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.

de Rooij DJ, Habets WJ, van de Putte LB, Hoet MH, Verbeek AL, van Venrooij WJ. de Rooij DJ, et al. Ann Rheum Dis. 1990 Jun;49(6):391-5. doi: 10.1136/ard.49.6.391. Ann Rheum Dis. 1990. PMID: 2383062 Free PMC article.

9

Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.

Habets WJ, Hoet MH, Sillekens PT, De Rooij DJ, Van de Putte LB, Van Venrooij WJ. Habets WJ, et al. Among authors: de rooij dj. Clin Exp Immunol. 1989 May;76(2):172-7. Clin Exp Immunol. 1989. PMID: 2527098 Free PMC article.

10

Anti-56K: a novel, frequently occurring autoantibody specificity in connective tissue disease.

van Venrooij WJ, Wodzig KW, Habets WJ, de Rooij DJ, van de Putte LB. van Venrooij WJ, et al. Among authors: de rooij dj. Clin Exp Rheumatol. 1989 May-Jun;7(3):277-82. Clin Exp Rheumatol. 1989. PMID: 2758708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters